Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus

The risk of hepatitis B virus (HBV) infection is higher in patients with diabetes mellitus, and diabetes mellitus is one of the metabolic complications of HBV infection. However, the cytokine profile of chronic hepatitis B (CHB) patients with type 2 diabetes mellitus (T2DM) is not fully understood....

Full description

Bibliographic Details
Main Authors: Wang He, Shu Hao, Xiaohui Dong, Dandan Zhang, Zhen Jia
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023-01-01
Series:Biomolecules & Biomedicine
Subjects:
Online Access:https://www.bjbms.org/ojs/index.php/bjbms/article/view/7525
_version_ 1797261274975830016
author Wang He
Shu Hao
Xiaohui Dong
Dandan Zhang
Zhen Jia
author_facet Wang He
Shu Hao
Xiaohui Dong
Dandan Zhang
Zhen Jia
author_sort Wang He
collection DOAJ
description The risk of hepatitis B virus (HBV) infection is higher in patients with diabetes mellitus, and diabetes mellitus is one of the metabolic complications of HBV infection. However, the cytokine profile of chronic hepatitis B (CHB) patients with type 2 diabetes mellitus (T2DM) is not fully understood. The aim of this study was to investigate the cytokine expression profile in CHB patients with T2DM, and to assess the regulatory function of cytokines to regulatory T cells (Tregs). Forty-four T2DM patients, 39 CHB patients, 17 patients with CHB and T2DM, and 21 control subjects were enrolled. Cytokine levels in the plasma were measured by Luminex multiplex assay. CD4+CD25+CD127dim/- Tregs were detected by flow cytometry. Tregs were purified and stimulated with recombinant human interleukin-15 (IL-15). The regulation of IL-15 on Tregs function was investigated by measuring cell number, IL-10/IL-35 secretion, and mRNA expression of immune checkpoint molecules in a Tregs+PBMC co-culture system. We found that levels of IL-1α, IL-6, and IL-33 were upregulated, while IFN-α, IL-2, IL-7, and IL-15 were downregulated in T2DM and CHB patients. CHB patients with T2DM had even lower plasma IL-7 and IL-15 levels. Tregs percentage was elevated in T2DM and CHB patients. CHB patients with T2DM had increased levels of Tregs, which correlated negatively with IL-15. Tregs showed stronger inhibitory activity in CHB patients with T2DM than in controls, T2DM, and CHB patients, which presented as reduction in cellular proliferation and induction of IL-10/IL-35 secretion. IL-15 suppressed Tregs function and inhibited the expression of immune checkpoint molecules in Tregs. The current data suggest that insufficient IL-15 levels and decreased responsiveness of Tregs to IL-15 signaling might contribute to strong immune dysfunction in CHB patients with T2DM.
first_indexed 2024-04-24T23:38:37Z
format Article
id doaj.art-07327cde5fc748bd8ee93b7b86c6b7db
institution Directory Open Access Journal
issn 2831-0896
2831-090X
language English
last_indexed 2024-04-24T23:38:37Z
publishDate 2023-01-01
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format Article
series Biomolecules & Biomedicine
spelling doaj.art-07327cde5fc748bd8ee93b7b86c6b7db2024-03-15T13:30:46ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2023-01-0123110.17305/bjbms.2022.7525Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitusWang He0Shu Hao1Xiaohui Dong2Dandan Zhang3Zhen Jia4https://orcid.org/0000-0002-0860-0962Department of Endocrinology, Xi’an No.1 Hospital, Xi’an, Shaanxi Province, ChinaDepartment of Endocrinology, Xi’an No.1 Hospital, Xi’an, Shaanxi Province, ChinaDepartment of Endocrinology, Xi’an No.1 Hospital, Xi’an, Shaanxi Province, ChinaDepartment of Endocrinology, Xi’an No.1 Hospital, Xi’an, Shaanxi Province, ChinaDepartment of Endocrinology, Xi’an No.1 Hospital, Xi’an, Shaanxi Province, ChinaThe risk of hepatitis B virus (HBV) infection is higher in patients with diabetes mellitus, and diabetes mellitus is one of the metabolic complications of HBV infection. However, the cytokine profile of chronic hepatitis B (CHB) patients with type 2 diabetes mellitus (T2DM) is not fully understood. The aim of this study was to investigate the cytokine expression profile in CHB patients with T2DM, and to assess the regulatory function of cytokines to regulatory T cells (Tregs). Forty-four T2DM patients, 39 CHB patients, 17 patients with CHB and T2DM, and 21 control subjects were enrolled. Cytokine levels in the plasma were measured by Luminex multiplex assay. CD4+CD25+CD127dim/- Tregs were detected by flow cytometry. Tregs were purified and stimulated with recombinant human interleukin-15 (IL-15). The regulation of IL-15 on Tregs function was investigated by measuring cell number, IL-10/IL-35 secretion, and mRNA expression of immune checkpoint molecules in a Tregs+PBMC co-culture system. We found that levels of IL-1α, IL-6, and IL-33 were upregulated, while IFN-α, IL-2, IL-7, and IL-15 were downregulated in T2DM and CHB patients. CHB patients with T2DM had even lower plasma IL-7 and IL-15 levels. Tregs percentage was elevated in T2DM and CHB patients. CHB patients with T2DM had increased levels of Tregs, which correlated negatively with IL-15. Tregs showed stronger inhibitory activity in CHB patients with T2DM than in controls, T2DM, and CHB patients, which presented as reduction in cellular proliferation and induction of IL-10/IL-35 secretion. IL-15 suppressed Tregs function and inhibited the expression of immune checkpoint molecules in Tregs. The current data suggest that insufficient IL-15 levels and decreased responsiveness of Tregs to IL-15 signaling might contribute to strong immune dysfunction in CHB patients with T2DM. https://www.bjbms.org/ojs/index.php/bjbms/article/view/7525Chronic hepatitis Bdiabetes mellituscytokineinterleukin-15regulatory T cells
spellingShingle Wang He
Shu Hao
Xiaohui Dong
Dandan Zhang
Zhen Jia
Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus
Biomolecules & Biomedicine
Chronic hepatitis B
diabetes mellitus
cytokine
interleukin-15
regulatory T cells
title Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus
title_full Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus
title_fullStr Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus
title_full_unstemmed Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus
title_short Circulating cytokine profile and modulation of regulatory T cells in chronic hepatitis B patients with type 2 diabetes mellitus
title_sort circulating cytokine profile and modulation of regulatory t cells in chronic hepatitis b patients with type 2 diabetes mellitus
topic Chronic hepatitis B
diabetes mellitus
cytokine
interleukin-15
regulatory T cells
url https://www.bjbms.org/ojs/index.php/bjbms/article/view/7525
work_keys_str_mv AT wanghe circulatingcytokineprofileandmodulationofregulatorytcellsinchronichepatitisbpatientswithtype2diabetesmellitus
AT shuhao circulatingcytokineprofileandmodulationofregulatorytcellsinchronichepatitisbpatientswithtype2diabetesmellitus
AT xiaohuidong circulatingcytokineprofileandmodulationofregulatorytcellsinchronichepatitisbpatientswithtype2diabetesmellitus
AT dandanzhang circulatingcytokineprofileandmodulationofregulatorytcellsinchronichepatitisbpatientswithtype2diabetesmellitus
AT zhenjia circulatingcytokineprofileandmodulationofregulatorytcellsinchronichepatitisbpatientswithtype2diabetesmellitus